Case 1: Primary Membranous Nephropathy & Anti-PLA2R Antibodies
Primary membranous nephropathy is an autoimmune glomerular disease caused by circulating autoantibodies (most commonly IgG4) against the podocyte cell-surface antigen M-type phospholipase A2 receptor (PLA2R).
- Clinical Recognition: The patient presents with classic nephrotic syndrome characterized by massive proteinuria (>3.5 g/day), hypoalbuminemia (<3.0 g/dL), peripheral edema, and normal renal function.
- Biopsy Correlation: Light microscopy showing diffuse capillary loop thickening without hypercellularity, combined with electron microscopy showing subepithelial deposits with 'spike and dome' basement membrane remodeling, establishes the diagnosis of membranous nephropathy (MN).
- Molecular Target: Primary (idiopathic) MN accounts for ~70-80% of adult membranous nephropathy cases and is mediated by autoantibodies against the M-type phospholipase A2 receptor (PLA2R) expressed on visceral epithelial cells (podocytes). Binding of anti-PLA2R antibodies activates the membrane attack complex (C5b-9), damaging the filtration barrier.
- Primary membranous nephropathy is strongly associated with autoantibodies against PLA2R; secondary causes include hepatitis B/C, systemic lupus erythematosus (Class V), solid tumors (colon, lung, prostate), and medications (NSAIDs, penicillamine).
- Silver stain on light microscopy highlights the subepithelial 'spikes' projecting around immune deposits.
